It would be worth investigating whether CISD2 also plays an oncogenic role in lung SQC and to explore its underlying mechanisms for identification of therapeutic targets in corresponding pathways for the effective treatment of lung cancers. This evidence concerns the gene CISD2 and lung carcinoma.